Voyager Therapeutics, Inc. Operating Income
Voyager Therapeutics, Inc. (VYGR) reported Operating Income of -$26.39 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-06
- Voyager Therapeutics, Inc. operating income (loss) for the quarter ending 2026-06-30 was -$26.39M.
- Voyager Therapeutics, Inc. operating income (loss) for the quarter ending 2026-03-31 was -$30.27M.
- Voyager Therapeutics, Inc. operating income (loss) for the quarter ending 2025-12-31 was -$29.93M.
- Voyager Therapeutics, Inc. operating income (loss) for the quarter ending 2025-09-30 was -$30.59M.
- Voyager Therapeutics, Inc. operating income (loss) for fiscal 2025 was -$131.84M.
- Voyager Therapeutics, Inc. operating income (loss) for fiscal 2024 was -$83.29M, a 168.26% decline from fiscal 2023.
- Voyager Therapeutics, Inc. operating income (loss) for fiscal 2023 was $122.01M.
- Voyager Therapeutics, Inc. operating income (loss) for fiscal 2022 was -$50.84M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$26.39M 10-Q · filed 2026-08-06 | -$56.66M 10-Q · filed 2026-08-06 | -$86.59M derived: sum of 3 quarters · filed 2026-08-06 | -$117.19M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$30.27M 10-Q · filed 2026-05-07 | -$60.20M derived: sum of 2 quarters · filed 2026-05-07 | -$90.80M derived: sum of 3 quarters · filed 2026-05-07 | -$127.42M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$29.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$60.53M derived: sum of 2 quarters · filed 2026-03-09 | -$97.15M derived: sum of 3 quarters · filed 2026-08-06 | -$131.84M 10-K · filed 2026-03-09 |
| 2025-09-30 | -$30.59M 10-Q · filed 2025-11-10 | -$67.22M derived: sum of 2 quarters · filed 2026-08-06 | -$101.91M 10-Q · filed 2025-11-10 | -$140.21M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$36.63M 10-Q · filed 2026-08-06 | -$71.32M 10-Q · filed 2026-08-06 | -$109.62M derived: sum of 3 quarters · filed 2026-08-06 | -$123.40M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$34.69M 10-Q · filed 2026-05-07 | -$72.99M derived: sum of 2 quarters · filed 2026-05-07 | -$86.77M derived: sum of 3 quarters · filed 2026-05-07 | -$101.80M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$38.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$52.08M derived: sum of 2 quarters · filed 2026-03-09 | -$67.10M derived: sum of 3 quarters · filed 2026-03-09 | -$83.29M 10-K · filed 2026-03-09 |
| 2024-09-30 | -$13.78M 10-Q · filed 2025-11-10 | -$28.80M derived: sum of 2 quarters · filed 2025-11-10 | -$44.99M 10-Q · filed 2025-11-10 | $9.07M derived: sum of 4 quarters · filed 2026-03-09 |
| 2024-06-30 | -$15.03M 10-Q · filed 2025-08-06 | -$31.21M 10-Q · filed 2025-08-06 | $22.86M derived: sum of 3 quarters · filed 2026-03-09 | -$6.65M derived: sum of 4 quarters · filed 2026-03-09 |
| 2024-03-31 | -$16.18M 10-Q · filed 2025-05-06 | $37.88M derived: sum of 2 quarters · filed 2026-03-09 | $8.37M derived: sum of 3 quarters · filed 2026-03-09 | -$17.05M derived: sum of 4 quarters · filed 2026-03-09 |
| 2023-12-31 | $54.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $24.56M derived: sum of 2 quarters · filed 2026-03-09 | -$870.00K derived: sum of 3 quarters · filed 2026-03-09 | $122.01M 10-K · filed 2026-03-09 |
| 2023-09-30 | -$29.51M 10-Q · filed 2024-11-12 | -$54.93M derived: sum of 2 quarters · filed 2024-11-12 | $67.95M 10-Q · filed 2024-11-12 | $43.39M derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-06-30 | -$25.43M 10-Q · filed 2024-08-06 | $97.46M 10-Q · filed 2024-08-06 | $72.89M derived: sum of 3 quarters · filed 2025-03-11 | $87.34M derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-03-31 | $122.88M 10-Q · filed 2024-05-13 | $98.32M derived: sum of 2 quarters · filed 2025-03-11 | $112.76M derived: sum of 3 quarters · filed 2025-03-11 | $93.40M derived: sum of 4 quarters · filed 2025-03-11 |
| 2022-12-31 | -$24.56M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | -$10.12M derived: sum of 2 quarters · filed 2025-03-11 | -$29.49M derived: sum of 3 quarters · filed 2025-03-11 | -$50.84M 10-K · filed 2025-03-11 |
| 2022-09-30 | $14.44M 10-Q · filed 2023-11-06 | -$4.92M derived: sum of 2 quarters · filed 2023-11-06 | -$26.27M 10-Q · filed 2023-11-06 | -$20.57M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | -$19.37M 10-Q · filed 2023-08-03 | -$40.72M 10-Q · filed 2023-08-03 | -$35.02M derived: sum of 3 quarters · filed 2024-02-28 | -$60.16M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | -$21.35M 10-Q · filed 2023-05-09 | -$15.65M derived: sum of 2 quarters · filed 2024-02-28 | -$40.79M derived: sum of 3 quarters · filed 2024-02-28 | -$69.38M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $5.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$19.44M derived: sum of 2 quarters · filed 2024-02-28 | -$48.03M derived: sum of 3 quarters · filed 2024-02-28 | -$73.62M 10-K · filed 2024-02-28 |
| 2021-09-30 | -$25.15M 10-Q · filed 2022-11-08 | -$53.73M derived: sum of 2 quarters · filed 2022-11-08 | -$79.32M 10-Q · filed 2022-11-08 | -$103.05M derived: sum of 4 quarters · filed 2023-03-07 |
| 2021-06-30 | -$28.59M 10-Q · filed 2022-08-04 | -$54.17M 10-Q · filed 2022-08-04 | -$77.90M derived: sum of 3 quarters · filed 2023-03-07 | $6.62M derived: sum of 4 quarters · filed 2023-03-07 |
| 2021-03-31 | -$25.59M 10-Q · filed 2022-05-04 | -$49.32M derived: sum of 2 quarters · filed 2023-03-07 | $35.21M derived: sum of 3 quarters · filed 2023-03-07 | $26.23M derived: sum of 4 quarters · filed 2023-03-07 |
| 2020-12-31 | -$23.73M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | $60.80M derived: sum of 2 quarters · filed 2023-03-07 | $51.82M derived: sum of 3 quarters · filed 2023-03-07 | $27.38M 10-K · filed 2023-03-07 |
| 2020-09-30 | $84.53M 10-Q · filed 2021-11-02 | $75.55M derived: sum of 2 quarters · filed 2021-11-02 | $51.11M 10-Q · filed 2021-11-02 | $37.34M derived: sum of 4 quarters · filed 2021-11-02 |
| 2020-06-30 | -$8.98M 10-Q · filed 2021-08-09 | -$33.41M 10-Q · filed 2021-08-09 | -$47.18M derived: sum of 3 quarters · filed 2021-08-09 | -$64.99M derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | -$24.43M 10-Q · filed 2021-05-10 | -$38.20M derived: sum of 2 quarters · filed 2021-05-10 | -$56.01M derived: sum of 3 quarters · filed 2021-05-10 | -$46.82M derived: sum of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | -$13.77M 10-K · filed 2020-03-03 | -$31.57M derived: sum of 2 quarters · filed 2020-11-09 | -$22.39M derived: sum of 3 quarters · filed 2020-11-09 | -$51.68M 10-K · filed 2022-03-08 |
| 2019-09-30 | -$17.81M 10-Q · filed 2020-11-09 | -$8.62M derived: sum of 2 quarters · filed 2020-11-09 | -$37.91M 10-Q · filed 2020-11-09 | -$61.07M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $9.19M 10-Q · filed 2020-08-10 | -$20.10M 10-Q · filed 2020-08-10 | -$43.27M derived: sum of 3 quarters · filed 2020-08-10 | -$64.41M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | -$29.29M 10-Q · filed 2020-05-06 | -$52.45M derived: sum of 2 quarters · filed 2020-05-06 | -$73.60M derived: sum of 3 quarters · filed 2020-05-06 | -$99.30M derived: sum of 4 quarters · filed 2020-05-06 |
| 2018-12-31 | -$23.16M 10-K · filed 2020-03-03 | -$44.31M derived: sum of 2 quarters · filed 2020-03-03 | -$70.00M derived: sum of 3 quarters · filed 2020-03-03 | -$91.09M 10-K · filed 2021-02-25 |
| 2018-09-30 | -$21.15M 10-K · filed 2020-03-03 | -$46.84M derived: sum of 2 quarters · filed 2020-03-03 | -$67.93M 10-Q · filed 2019-11-06 | -$80.28M derived: sum of 4 quarters · filed 2020-03-03 |
| 2018-06-30 | -$25.69M 10-K · filed 2020-03-03 | -$46.79M 10-Q · filed 2019-08-09 | -$59.13M derived: sum of 3 quarters · filed 2020-03-03 | -$82.49M derived: sum of 4 quarters · filed 2020-03-03 |
| 2018-03-31 | -$21.09M 10-K · filed 2020-03-03 | -$33.44M derived: sum of 2 quarters · filed 2020-03-03 | -$56.80M derived: sum of 3 quarters · filed 2020-03-03 | -$75.43M derived: sum of 4 quarters · filed 2020-03-03 |
| 2017-12-31 | -$12.35M 10-K · filed 2019-02-26 | -$35.70M derived: sum of 2 quarters · filed 2019-02-26 | -$54.34M derived: sum of 3 quarters · filed 2019-02-26 | -$71.86M 10-K · filed 2020-03-03 |
| 2017-09-30 | -$23.36M 10-K · filed 2019-02-26 | -$41.99M derived: sum of 2 quarters · filed 2019-02-26 | -$59.52M 10-Q · filed 2018-11-07 | -$73.36M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | -$18.64M 10-K · filed 2019-02-26 | -$36.16M 10-Q · filed 2018-08-07 | -$50.00M derived: sum of 3 quarters · filed 2019-02-26 | -$60.38M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | -$17.52M 10-K · filed 2019-02-26 | -$31.36M derived: sum of 2 quarters · filed 2019-02-26 | -$41.74M derived: sum of 3 quarters · filed 2019-02-26 | -$51.35M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | -$13.84M 10-K · filed 2018-03-14 | -$24.21M derived: sum of 2 quarters · filed 2018-03-14 | -$33.83M derived: sum of 3 quarters · filed 2018-03-14 | -$41.30M 10-K · filed 2019-02-26 |
| 2016-09-30 | -$10.37M 10-K · filed 2018-03-14 | -$19.99M derived: sum of 2 quarters · filed 2018-03-14 | -$27.46M 10-Q · filed 2017-11-02 | -$34.90M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-06-30 | -$9.62M 10-K · filed 2018-03-14 | -$17.09M 10-Q · filed 2017-08-08 | -$24.52M derived: sum of 3 quarters · filed 2018-03-14 | -$28.54M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-03-31 | -$7.47M 10-K · filed 2018-03-14 | -$14.91M derived: sum of 2 quarters · filed 2018-03-14 | -$18.93M derived: sum of 3 quarters · filed 2018-03-14 | -$22.89M derived: sum of 4 quarters · filed 2018-03-14 |
| 2015-12-31 | -$7.44M 10-K · filed 2017-03-15 | -$11.46M derived: sum of 2 quarters · filed 2017-03-15 | -$15.43M derived: sum of 3 quarters · filed 2017-03-15 | -$20.25M 10-K · filed 2018-03-14 |
| 2015-09-30 | -$4.02M 10-K · filed 2017-03-15 | -$7.99M derived: sum of 2 quarters · filed 2017-03-15 | -$12.81M 10-Q · filed 2016-11-10 | -$17.31M derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-06-30 | -$3.97M 10-K · filed 2017-03-15 | -$8.79M 10-Q · filed 2016-08-11 | -$13.29M derived: sum of 3 quarters · filed 2017-03-15 | -$16.95M derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-03-31 | -$4.83M 10-K · filed 2017-03-15 | -$9.32M derived: sum of 2 quarters · filed 2017-03-15 | -$12.98M derived: sum of 3 quarters · filed 2017-03-15 | -$16.21M derived: sum of 4 quarters · filed 2017-03-15 |
| 2014-12-31 | -$4.50M 10-K · filed 2016-03-17 | -$8.15M derived: sum of 2 quarters · filed 2016-03-17 | -$11.38M derived: sum of 3 quarters · filed 2016-03-17 | -$14.37M 10-K · filed 2017-03-15 |
| 2014-09-30 | -$3.66M 10-K · filed 2016-03-17 | -$6.89M derived: sum of 2 quarters · filed 2016-03-17 | -$9.87M 10-Q · filed 2015-12-17 | |
| 2014-06-30 | -$3.23M 10-K · filed 2016-03-17 | -$6.21M derived: sum of 2 quarters · filed 2016-03-17 | ||
| 2014-03-31 | -$2.98M 10-K · filed 2016-03-17 | |||
| 2013-12-31 | -$3.77M 10-K · filed 2016-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |